Business Description
![ConvaTec Group PLC ConvaTec Group PLC logo](https://static.gurufocus.com/logos/0C00004X2B.png?14)
ConvaTec Group PLC
ISIN : GB00BD3VFW73
Description
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.78 | |||||
Debt-to-EBITDA | 2.88 | |||||
Interest Coverage | 3.62 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.5 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.5 | |||||
3-Year EBITDA Growth Rate | 4.4 | |||||
3-Year EPS without NRI Growth Rate | 6 | |||||
3-Year FCF Growth Rate | -7.4 | |||||
3-Year Book Growth Rate | 1.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 9.57 | |||||
Future 3-5Y Total Revenue Growth Rate | 4.49 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.91 | |||||
9-Day RSI | 52.89 | |||||
14-Day RSI | 48.12 | |||||
6-1 Month Momentum % | 10.33 | |||||
12-1 Month Momentum % | 27 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.62 | |||||
Quick Ratio | 0.88 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 148.99 | |||||
Days Sales Outstanding | 55.08 | |||||
Days Payable | 76.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.93 | |||||
Dividend Payout Ratio | 0.47 | |||||
3-Year Dividend Growth Rate | 6.8 | |||||
Forward Dividend Yield % | 1.93 | |||||
5-Year Yield-on-Cost % | 2.07 | |||||
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 2.31 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.04 | |||||
Operating Margin % | 12.38 | |||||
Net Margin % | 6.08 | |||||
FCF Margin % | 11.11 | |||||
ROE % | 7.83 | |||||
ROA % | 3.49 | |||||
ROIC % | 6.12 | |||||
ROC (Joel Greenblatt) % | 31.29 | |||||
ROCE % | 7.55 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 51.39 | |||||
Forward PE Ratio | 20.33 | |||||
PE Ratio without NRI | 23.75 | |||||
Shiller PE Ratio | 225.02 | |||||
Price-to-Owner-Earnings | 22.68 | |||||
PEG Ratio | 29.69 | |||||
PS Ratio | 3.05 | |||||
PB Ratio | 3.86 | |||||
Price-to-Free-Cash-Flow | 27.37 | |||||
Price-to-Operating-Cash-Flow | 17.86 | |||||
EV-to-EBIT | 32.23 | |||||
EV-to-Forward-EBIT | 20.36 | |||||
EV-to-EBITDA | 17.02 | |||||
EV-to-Forward-EBITDA | 13.25 | |||||
EV-to-Revenue | 3.63 | |||||
EV-to-Forward-Revenue | 3.5 | |||||
EV-to-FCF | 32.47 | |||||
Price-to-Projected-FCF | 1.78 | |||||
Earnings Yield (Greenblatt) % | 3.12 | |||||
FCF Yield % | 3.63 | |||||
Forward Rate of Return (Yacktman) % | 4.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ConvaTec Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | 1,694.607 | ||
EPS (TTM) (£) | 0.049 | ||
Beta | 0.68 | ||
Volatility % | 22.72 | ||
14-Day RSI | 48.12 | ||
14-Day ATR (£) | 0.054974 | ||
20-Day SMA (£) | 2.5089 | ||
12-1 Month Momentum % | 27 | ||
52-Week Range (£) | 1.953 - 2.952 | ||
Shares Outstanding (Mil) | 2,049.79 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ConvaTec Group PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ConvaTec Group PLC Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
ConvaTec Group PLC Frequently Asked Questions
What is ConvaTec Group PLC(CHIX:CTECl)'s stock price today?
The current price of CHIX:CTECl is £2.53. The 52 week high of CHIX:CTECl is £2.95 and 52 week low is £1.95.
When is next earnings date of ConvaTec Group PLC(CHIX:CTECl)?
The next earnings date of ConvaTec Group PLC(CHIX:CTECl) is 2024-08-02 Est..
Does ConvaTec Group PLC(CHIX:CTECl) pay dividends? If so, how much?
The Dividend Yield %  of ConvaTec Group PLC(CHIX:CTECl) is 1.93% (As of Today), Highest Dividend Payout Ratio of ConvaTec Group PLC(CHIX:CTECl) was 0.49. The lowest was 0.08. And the median was 0.46. The  Forward Dividend Yield % of ConvaTec Group PLC(CHIX:CTECl) is 1.93%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |